Publications

  1. Klein CJ, Beecher G, Lamb C, Naddaf E, Milone M, Liewluck T, Dubey D, Zekeridou A, Shelly S, Mills JR. LRP4-IgG service line testing in seronegative myasthenia gravis and controls. J Neuroimmunol. 2022 Jul 15; 368:577895 Epub 2022 May 18
    View PubMed
  2. Bartley CM, Ngo TT, Alvarenga BD, Kung AF, Teliska LH, Sy M, DeRisi JL, Rasband MN, Pittock SJ, Dubey D, Wilson MR, Pleasure SJ. betaIV-Spectrin Autoantibodies in 2 Individuals With Neuropathy of Possible Paraneoplastic Origin: A Case Series. Neurol Neuroimmunol Neuroinflamm. 2022 Jul; 9 (4) Epub 2022 May 17
    View PubMed
  3. Dubey D, Beecher G, Hammami MB, Knight AM, Liewluck T, Triplett J, Datta A, Dasari S, Zhang Y, Roforth MM, Jerde CR, Murphy SJ, Litchy WJ, Amato A, Lennon VA, McKeon A, Mills JR, Pittock SJ, Milone M. Identification of Caveolae-Associated Protein 4 Autoantibodies as a Biomarker of Immune-Mediated Rippling Muscle Disease in Adults. JAMA Neurol. 2022 Jun 13 Epub 2022 June 13
    View PubMed
  4. Ganaraja VH, Rezk M, Dubey D. Paraneoplastic neurological syndrome: growing spectrum and relevance. Neurol Sci. 2022 Jun; 43 (6):3583-3594 Epub 2022 Apr 23
    View PubMed
  5. Shelly S, Beecher G, Milone M, Liewluck T, Ernste F, Triplett J, Naddaf E, Zekeridou A, McKeon A, Pittock SJ, Dubey D, Mills JR, Mandrekar J, Klein CJ. Cancer and immune-mediated necrotizing myopathy: A longitudinal referral case-controlled outcomes evaluation. Rheumatology (Oxford). 2022 Mar 14 [Epub ahead of print]
    View PubMed
  6. Rodriguez A, Klein CJ, Sechi E, Alden E, Basso MR, Pudumjee S, Pittock SJ, McKeon A, Britton JW, Lopez-Chiriboga AS, Zekeridou A, Zalewski NL, Boeve BF, Day GS, Gadoth A, Burkholder D, Toledano M, Dubey D, Flanagan EP. LGI1 antibody encephalitis: acute treatment comparisons and outcome. J Neurol Neurosurg Psychiatry. 2022 Mar; 93 (3):309-315 Epub 2021 Nov 25
    View PubMed
  7. Peris Sempere V, Muniz-Castrillo S, Ambati A, Binks S, Pinto AL, Rogemond V, Pittock SJ, Dubey D, Geschwind MD, Gelfand JM, Dilwali S, Lee ST, Knight J, Elliott KS, Irani S, Honnorat J, Mignot E. Human Leukocyte Antigen Association Study Reveals DRB1*04:02 Effects Additional to DRB1*07:01 in Anti-LGI1 Encephalitis. Neurol Neuroimmunol Neuroinflamm. 2022 Mar; 9 (2) Epub 2022 Feb 03
    View PubMed
  8. Shah S, Flanagan EP, Paul P, Smith CY, Bryant SC, Devine MF, Lennon VA, McKeon A, Pittock SJ, Dubey D. Population-Based Epidemiology Study of Paraneoplastic Neurologic Syndromes. Neurol Neuroimmunol Neuroinflamm. 2022 Mar; 9 (2) Epub 2021 Dec 22
    View PubMed
  9. Kunchok A, McKeon A, Zekeridou A, Flanagan EP, Dubey D, Lennon VA, Klein CJ, Mills JR, Pittock SJ. Autoimmune/Paraneoplastic Encephalitis Antibody Biomarkers: Frequency, Age, and Sex Associations. Mayo Clin Proc. 2022 Mar; 97 (3):547-559 Epub 2021 Dec 23
    View PubMed
  10. Garrido Sanabria ER, Zahid A, Britton J, Kraus GJ, Lopez-Chiriboga AS, Zekeridou A, Flanagan EP, McKeon A, Mills JR, Pittock SJ, Dubey D. CASPR2-IgG-associated autoimmune seizures. Epilepsia. 2022 Mar; 63 (3):709-722 Epub 2022 Jan 15
    View PubMed
  11. Devine MF, Feemster JC, Lieske EA, McCarter SJ, Sandness DJ, Steele T, Timm PC, Mandrekar J, Boeve BF, Silber MH, Dubey D, McKeon A, St Louis EK. Objective sleep profile in LGI1/CASPR2 autoimmunity. Sleep. 2022 Feb 14; 45 (2)
    View PubMed
  12. Valencia-Sanchez C, Knight AM, Hammami MB, Guo Y, Mills JR, Kryzer TJ, Piquet AL, Amin A, Heinzelmann M, Lucchinetti CF, Lennon VA, McKeon A, Pittock SJ, Dubey D. Characterisation of TRIM46 autoantibody-associated paraneoplastic neurological syndrome. J Neurol Neurosurg Psychiatry. 2022 Feb; 93 (2):196-200 Epub 2021 Dec 17
    View PubMed
  13. Budhram A, Yang L, Bhayana V, Mills JR, Dubey D. Clinical Sensitivity, Specificity, and Predictive Value of Neural Antibody Testing for Autoimmune Encephalitis. J Appl Lab Med. 2022 Jan 5; 7 (1):350-356
    View PubMed
  14. Chompoopong P, Zekeridou A, Shelly S, Ruff M, Dyck PJ, Klein CJ, Pittock SJ, Mauermann M, Dubey D. Comparison of immune checkpoint inhibitor-related neuropathies among patients with neuroendocrine and non-neuroendocrine tumours. J Neurol Neurosurg Psychiatry 2022 Jan; 93 (1):112-114 Epub 2021 May 26
    View PubMed
  15. Majed M, Madhavan AA, Pittock SJ, Dubey D. "Hot Cross Bun" Sign in a Patient With Kelch-like Protein 11 Rhombencephalitis. Mayo Clin Proc. 2022 Jan; 97 (1):122-123
    View PubMed
  16. Shelly S, Klein CJ, Dyck PJB, Paul P, Mauermann ML, Berini SE, Howe B, Fryer JP, Basal E, Bakri HM, Laughlin RS, McKeon A, Pittock SJ, Mills J, Dubey D. Neurofascin-155 Immunoglobulin Subtypes: Clinicopathologic Associations and Neurologic Outcomes. Neurology. 2021 Dec 14; 97 (24):e2392-e2403 Epub 2021 Oct 11
    View PubMed
  17. Johnson SA, Shouman K, Shelly S, Sandroni P, Berini SE, Dyck PJB, Hoffman EM, Mandrekar J, Niu Z, Lamb CJ, Low PA, Singer W, Mauermann ML, Mills J, Dubey D, Staff NP, Klein CJ. Small Fiber Neuropathy Incidence, Prevalence, Longitudinal Impairments, and Disability. Neurology. 2021 Nov 30; 97 (22):e2236-e2247 Epub 2021 Oct 27
    View PubMed
  18. Hammami MB, Eggers SDZ, Madhavan A, Montalvo MJ, Pittock SJ, Dubey D. Paraneoplastic cochleovestibulopathy: clinical presentations, oncological and serological associations. J Neurol Neurosurg Psychiatry. 2021 Nov; 92 (11):1181-1185 Epub 2021 July 20
    View PubMed
  19. Zhao-Fleming HH, Valencia Sanchez C, Sechi E, Inbarasu J, Wijdicks EF, Pittock SJ, Chen JJ, Wingerchuk DM, Weinshenker BG, Lopez-Chiriboga S, Dubey D, Tillema JM, Toledano M, Yadav H, Flanagan EP. CNS Demyelinating Attacks Requiring Ventilatory Support With Myelin Oligodendrocyte Glycoprotein or Aquaporin-4 Antibodies. Neurology. 2021 Sep 28; 97 (13):e1351-e1358 Epub 2021 Aug 13
    View PubMed
  20. Smith KM, Dubey D, Liebo GB, Flanagan EP, Britton JW. Clinical Course and Features of Seizures Associated With LGI1-Antibody Encephalitis. Neurology. 2021 Sep 14; 97 (11):e1141-e1149 Epub 2021 July 07
    View PubMed
  21. Zahid A, Shah S, Martinez-Thompson JM, Arment CA, Huang Y, Sturgis CD, Dubey D. Clinical Reasoning: A 49-Year-Old Woman With Progressive Numbness and Gait Instability. Neurology. 2021 Aug 17; 97 (7):342-347 Epub 2021 Apr 30
    View PubMed
  22. Beecher G, Shelly S, Dyck PJB, Mauermann ML, Martinez-Thompson JM, Berini SE, Naddaf E, Shouman K, Taylor BV, Dyck PJB, Engelstad J, Howe BM, Mills JR, Dubey D, Spinner RJ, Klein CJ. Pure Motor Onset and IgM-Gammopathy Occurrence in Multifocal Acquired Demyelinating Sensory and Motor Neuropathy. Neurology. 2021 Aug 10. [Epub ahead of print]
    View PubMed
  23. Jitprapaikulsan J, Paul P, Thakolwiboon S, Mittal SO, Pittock SJ, Dubey D. Paraneoplastic neurological syndrome: an evolving story. Neurooncol Pract. 2021 Aug; 8 (4):362-374 Epub 2021 Feb 24
    View PubMed
  24. Devine MF, Gay PC, Dubey D. Ondine's Curse and Trismus in Association With Kelch-like Protein-11 Autoimmunity. JAMA Neurol. 2021 Aug 1; 78 (8):1016-1017
    View PubMed
  25. Madhavan A, Carr CM, Krecke KN, Wood CP, McKeon A, Dubey D. Association between paraneoplastic rhombencephalitis and hypertrophic olivary degeneration. J Neurol Neurosurg Psychiatry 2021 Jul; 92 (7):798-800 Epub 2021 Jan 15
    View PubMed
  26. Graus F, Vogrig A, Muniz-Castrillo S, Antoine JG, Desestret V, Dubey D, Giometto B, Irani SR, Joubert B, Leypoldt F, McKeon A, Pruss H, Psimaras D, Thomas L, Titulaer MJ, Vedeler CA, Verschuuren JJ, Dalmau J, Honnorat J. Updated Diagnostic Criteria for Paraneoplastic Neurologic Syndromes. Neurol Neuroimmunol Neuroinflamm. 2021 Jul; 8 (4) Epub 2021 May 18
    View PubMed
  27. Guidon AC, Burton LB, Chwalisz BK, Hillis J, Schaller TH, Amato AA, Betof Warner A, Brastianos PK, Cho TA, Clardy SL, Cohen JV, Dietrich J, Dougan M, Doughty CT, Dubey D, Gelfand JM, Guptill JT, Johnson DB, Juel VC, Kadish R, Kolb N, LeBoeuf NR, Linnoila J, Mammen AL, Martinez-Lage M, Mooradian MJ, Naidoo J, Neilan TG, Reardon DA, Rubin KM, Santomasso BD, Sullivan RJ, Wang N, Woodman K, Zubiri L, Louv WC, Reynolds KL. Consensus disease definitions for neurologic immune-related adverse events of immune checkpoint inhibitors. J Immunother Cancer. 2021 Jul; 9 (7)
    View PubMed
  28. Kattah JC, Eggers SD, Bach SE, Dubey D, McKeon AB. Paraneoplastic Progressive Downbeat Nystagmus, Ataxia and Sensorineural Hearing Loss due to the ANTI-Kelch-11 Protein Antibody. J Neuroophthalmol. 2021 Jun 1; 41 (2):261-265
    View PubMed
  29. Chen JJ, McKeon A, Greenwood TM, Flanagan EP, Bhatti MT, Dubey D, Pulido JS, Iezzi R, Smith WM, Sen HN, Gordon LK, Pittock SJ. Clinical Utility of Antiretinal Antibody Testing. JAMA Ophthalmol. 2021 Jun 1; 139 (6):658-662
    View PubMed
  30. Bohm P, Eggenberger ER, Dubey D, Kim HW, Lopez Chiriboga AS. Teaching Video NeuroImages: Periodic Alternating Nystagmus in Paraneoplastic KLHL11 Rhomboencephalitis. Neurology. 2021 May 25; 96 (21):e2668-e2669 Epub 2021 Feb 15
    View PubMed
  31. Dubey D, Kryzer T, Guo Y, Clarkson B, Cheville JC, Costello BA, Leibovich BC, Algeciras-Schimnich A, Lucchinnetti C, Hammami MB, Knight AM, Howe C, Lennon VA, McKeon A, Pittock SJ. Leucine Zipper 4 Autoantibody: A Novel Germ Cell Tumor and Paraneoplastic Biomarker. Ann Neurol. 2021 May; 89 (5):1001-1010 Epub 2021 Feb 28
    View PubMed
  32. Shouman K, Dubey D, Engelstad JK, Dyck PJB. Focal sensory chronic inflammatory demyelinating polyneuropathy (CIDP). Muscle Nerve 2021 May; 63 (5):E46-E49 Epub 2021 Mar 03
    View PubMed
  33. Smith KM, Zalewski NL, Budhram A, Britton JW, So E, Cascino GD, Ritaccio AL, McKeon A, Pittock SJ, Dubey D. Musicogenic epilepsy: Expanding the spectrum of glutamic acid decarboxylase 65 neurological autoimmunity. Epilepsia. 2021 May; 62 (5):e76-e81 Epub 2021 Mar 25
    View PubMed
  34. Shelly S, Mills JR, Dubey D, McKeon A, Zekeridou A, Pittock SJ, Harper CM, Naddaf E, Milone M, Mandrekar J, Klein CJ. Clinical Utility of Striational Antibodies in Paraneoplastic and Myasthenia Gravis Paraneoplastic Panels. Neurology. 2021 Apr 26 [Epub ahead of print]
    View PubMed
  35. Shelly S, Shouman K, Paul P, Engelstad J, Amrami KK, Spinner RJ, Dubey D, Vazquez Do Campo R, Dyck PJ, Klein CJ, Dyck PJB. Expanding the Spectrum of Chronic Immune Sensory Polyradiculopathy: CISP-Plus. Neurology. 2021 Apr 20; 96 (16):e2078-e2089 Epub 2021 Mar 02
    View PubMed
  36. Budhram A, Rech KL, Peikert JM, Okuno SH, Go RS, Dubey D, Tobin WO. Teaching NeuroImages: Brain and Skin Involvement in Erdheim-Chester Disease. Neurology. 2021 Mar 16; 96 (11):e1590-e1592 Epub 2020 Nov 09
    View PubMed
  37. Budhram A, Sechi E, Flanagan EP, Dubey D, Zekeridou A, Shah SS, Gadoth A, Naddaf E, McKeon A, Pittock SJ, Zalewski NL. Clinical spectrum of high-titre GAD65 antibodies. J Neurol Neurosurg Psychiatry. 2021 Feb 9 Epub 2021 Feb 09
    View PubMed
  38. Sechi E, Krecke KN, Pittock SJ, Dubey D, Lopez-Chiriboga AS, Kunchok A, Weinshenker BG, Zalewski NL, Flanagan EP. Frequency and characteristics of MRI-negative myelitis associated with MOG autoantibodies. Mult Scler. 2021 Feb; 27 (2):303-308 Epub 2020 Feb 27
    View PubMed
  39. McKeon A, Shelly S, Zivelonghi C, Basal E, Dubey D, Flanagan E, Madhavan AA, Mariotto S, Toledano M, Tracy JA, Zekeridou A, Pittock SJ. Neuronal intermediate filament IgGs in CSF: Autoimmune Axonopathy Biomarkers. Ann Clin Transl Neurol. 2021 Feb; 8 (2):425-439 Epub 2020 Dec 28
    View PubMed
  40. Shah S, Vazquez Do Campo R, Kumar N, McKeon A, Flanagan EP, Klein C, Pittock SJ, Dubey D. Paraneoplastic Myeloneuropathies: Clinical, Oncologic, and Serologic Accompaniments. Neurology. 2021 Jan 26; 96 (4):e632-e639 Epub 2020 Nov 18
    View PubMed
  41. Devine MF, Kothapalli N, Elkhooly M, Dubey D. Paraneoplastic neurological syndromes: clinical presentations and management. Ther Adv Neurol Disord. 2021; 14:1756286420985323 Epub 2021 Feb 01
    View PubMed
  42. Valencia-Sanchez C, Pittock SJ, Mead-Harvey C, Dubey D, Flanagan EP, Lopez-Chiriboga S, Trenerry MR, Zalewski NL, Zekeridou A, McKeon A. Brain dysfunction and thyroid antibodies: autoimmune diagnosis and misdiagnosis. Brain Commun. 2021; 3 (2):fcaa233 Epub 2021 Jan 05
    View PubMed
  43. Shelly S, Paul P, Bi H, Dubey D, Milone M, Sorenson EJ, Crum BA, Laughlin RS, Liewluck T, Mandrekar J, Pittock SJ, Zekeridou A, McKeon A, Harper MC, Mills JR, Klein CJ. Improving accuracy of myasthenia gravis autoantibody testing by reflex algorithm. Neurology. 2020 Dec 1; 95 (22):e3002-e3011 Epub 2020 Sept 16
    View PubMed
  44. Budhram A, Dubey D, Sechi E, Flanagan EP, Yang L, Bhayana V, McKeon A, Pittock SJ, Mills JR. Neural Antibody Testing in Patients with Suspected Autoimmune Encephalitis. Clin Chem. 2020 Dec 1; 66 (12):1496-1509
    View PubMed
  45. Budhram A, Britton JW, Liebo GB, Dubey D, Zekeridou A, Flanagan EP, McKeon A, Pittock SJ, Braksick SA, Zalewski NL. Use of diffusion-weighted imaging to distinguish seizure-related change from limbic encephalitis. J Neurol. 2020 Nov; 267 (11):3337-3342 Epub 2020 June 24
    View PubMed
  46. Dubey D, Wilson MR, Clarkson B, Giannini C, Gandhi M, Cheville J, Lennon VA, Eggers S, Devine MF, Mandel-Brehm C, Kryzer T, Hinson SR, Khazaie K, Hales C, Kattah J, Pavelko KD, Andrews P, Eaton JE, Jitprapaikulsan J, Mills JR, Flanagan EP, Zekeridou A, Leibovich B, Fryer J, Torre M, Kaufman C, Thoreson JB, Sagen J, Linnoila JJ, DeRisi JL, Howe CL, McKeon A, Pittock SJ. Expanded Clinical Phenotype, Oncological Associations, and Immunopathologic Insights of Paraneoplastic Kelch-like Protein-11 Encephalitis. JAMA Neurol. 2020 Nov 1; 77 (11):1420-1429
    View PubMed
  47. Sechi E, Markovic SN, McKeon A, Dubey D, Liewluck T, Lennon VA, Lopez-Chiriboga AS, Klein CJ, Mauermann M, Pittock SJ, Flanagan EP, Zekeridou A. Neurologic autoimmunity and immune checkpoint inhibitors: Autoantibody profiles and outcomes. Neurology. 2020 Oct 27; 95 (17):e2442-e2452 Epub 2020 Aug 13
    View PubMed
  48. Chen JJ, Flanagan EP, Bhatti MT, Jitprapaikulsan J, Dubey D, Lopez Chiriboga ASS, Fryer JP, Weinshenker BG, McKeon A, Tillema JM, Lennon VA, Lucchinetti CF, Kunchok A, McClelland CM, Lee MS, Bennett JL, Pelak VS, Van Stavern G, Adesina OO, Eggenberger ER, Acierno MD, Wingerchuk DM, Lam BL, Moss H, Beres S, Gilbert AL, Shah V, Armstrong G, Heidary G, Cestari DM, Stiebel-Kalish H, Pittock SJ. Steroid-sparing maintenance immunotherapy for MOG-IgG associated disorder. Neurology. 2020 Jul 14; 95 (2):e111-e120 Epub 2020 June 17
    View PubMed
  49. Dubey D, Honorat JA, Shelly S, Klein CJ, Komorowski L, Mills JR, Brakopp S, Probst C, Lennon VA, Pittock SJ, McKeon A. Contactin-1 autoimmunity: Serologic, neurologic, and pathologic correlates. Neurol Neuroimmunol Neuroinflamm. 2020 Jul; 7 (4) Epub 2020 May 27
    View PubMed
  50. Paul P, McKeon A, Pittock SJ, Klein CJ, Shah S, Toledano M, Mills JR, Dubey D. GFAP IgG associated inflammatory polyneuropathy. J Neuroimmunol. 2020 Jun 15; 343:577233 Epub 2020 Apr 01
    View PubMed
  51. Dubey D, David WS, Reynolds KL, Chute DF, Clement NF, Cohen JV, Lawrence DP, Mooradian MJ, Sullivan RJ, Guidon AC. Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing Spectrum. Ann Neurol. 2020 May; 87 (5):659-669 Epub 2020 Mar 10
    View PubMed
  52. Shelly S, Mills JR, Martinez-Thompson JM, Rofforth MM, Pittock SJ, Mandrekar J, Triplett JD, Mauermann M, Dubey D, Klein CJ. IgM-gammopathy strongly favours immune treatable MMN and MADSAM over ALS. J Neurol Neurosurg Psychiatry 2020 Mar; 91 (3):324-326 Epub 2019 Nov 22
    View PubMed
  53. Jitprapaikulsan J, Klein CJ, Pittock SJ, Gadoth A, McKeon A, Mills JR, Dubey D. Phenotypic presentations of paraneoplastic neuropathies associated with MAP1B-IgG. J Neurol Neurosurg Psychiatry 2020 Mar; 91 (3):328-330 Epub 2019 Dec 04
    View PubMed
  54. Cohen DA, Bhatti MT, Pulido JS, Lennon VA, Dubey D, Flanagan EP, Pittock SJ, Klein CJ, Chen JJ. Collapsin Response-Mediator Protein 5-Associated Retinitis, Vitritis, and Optic Disc Edema. Ophthalmology. 2020 Feb; 127 (2):221-229 Epub 2019 Sept 20
    View PubMed
  55. Dubey D, Britton J, McKeon A, Gadoth A, Zekeridou A, Lopez Chiriboga SA, Devine M, Cerhan JH, Dunlay K, Sagen J, Ramberger M, Waters P, Irani SR, Pittock SJ. Randomized Placebo-Controlled Trial of Intravenous Immunoglobulin in Autoimmune LGI1/CASPR2 Epilepsy. Ann Neurol. 2020 Feb; 87 (2):313-323 Epub 2019 Dec 14
    View PubMed
  56. Triplett JD, Shelly S, Livne G, Milone M, Kassardjian CD, Liewluck T, Kelly C, Naddaf E, Laughlin RS, Lamb CJ, Rubin D, Dimberg EL, Dubey D, Mills JR, Mandrekar J, Klein CJ. Diagnostic modelling and therapeutic monitoring of immune-mediated necrotizing myopathy: role of electrical myotonia. Brain Commun. 2020; 2 (2):fcaa191 Epub 2020 Dec 13
    View PubMed
  57. Dubey D, Jitprapaikulsan J, Bi H, Do Campo RV, McKeon A, Pittock SJ, Engelstad JK, Mills JR, Klein CJ. Amphiphysin-IgG autoimmune neuropathy: A recognizable clinicopathologic syndrome. Neurology. 2019 Nov 12; 93 (20):e1873-e1880 Epub 2019 Oct 17
    View PubMed
  58. Dubey D, David WS, Amato AA, Reynolds KL, Clement NF, Chute DF, Cohen JV, Lawrence DP, Mooradian MJ, Sullivan RJ, Guidon AC. Varied phenotypes and management of immune checkpoint inhibitor-associated neuropathies. Neurology. 2019 Sep 10; 93 (11):e1093-e1103 Epub 2019 Aug 12
    View PubMed
  59. Mandel-Brehm C, Dubey D, Kryzer TJ, O'Donovan BD, Tran B, Vazquez SE, Sample HA, Zorn KC, Khan LM, Bledsoe IO, McKeon A, Pleasure SJ, Lennon VA, DeRisi JL, Wilson MR, Pittock SJ. Kelch-like Protein 11 Antibodies in Seminoma-Associated Paraneoplastic Encephalitis. N Engl J Med. 2019 Jul 4; 381 (1):47-54
    View PubMed
  60. Husari KS, Dubey D. Autoimmune Epilepsy. Neurotherapeutics. 2019 Jul; 16 (3):685-702
    View PubMed
  61. Dubey D, Pittock SJ, Krecke KN, Morris PP, Sechi E, Zalewski NL, Weinshenker BG, Shosha E, Lucchinetti CF, Fryer JP, Lopez-Chiriboga AS, Chen JC, Jitprapaikulsan J, McKeon A, Gadoth A, Keegan BM, Tillema JM, Naddaf E, Patterson MC, Messacar K, Tyler KL, Flanagan EP. Clinical, Radiologic, and Prognostic Features of Myelitis Associated With Myelin Oligodendrocyte Glycoprotein Autoantibody. JAMA Neurol. 2019 Mar 1; 76 (3):301-309
    View PubMed
  62. Dubey D, Pittock SJ, McKeon A. Antibody Prevalence in Epilepsy and Encephalopathy score: Increased specificity and applicability. Epilepsia 2019 Feb; 60 (2):367-369
    View PubMed
  63. Narapureddy B, Dubey D. Clinical evaluation of dimethyl fumarate for the treatment of relapsing-remitting multiple sclerosis: efficacy, safety, patient experience and adherence. Patient Prefer Adherence. 2019; 13:1655-1666 Epub 2019 Oct 01
    View PubMed
  64. Mittal SO, Machado D, Richardson D, Dubey D, Jabbari B. Botulinum toxin in essential hand tremor - A randomized double-blind placebo-controlled study with customized injection approach. Parkinsonism Relat Disord. 2018 Nov; 56:65-69 Epub 2018 June 12
    View PubMed
  65. Lopez-Chiriboga AS, Majed M, Fryer J, Dubey D, McKeon A, Flanagan EP, Jitprapaikulsan J, Kothapalli N, Tillema JM, Chen J, Weinshenker B, Wingerchuk D, Sagen J, Gadoth A, Lennon VA, Keegan BM, Lucchinetti C, Pittock SJ. Association of MOG-IgG Serostatus With Relapse After Acute Disseminated Encephalomyelitis and Proposed Diagnostic Criteria for MOG-IgG-Associated Disorders. JAMA Neurol. 2018 Nov 1; 75 (11):1355-1363
    View PubMed
  66. Basal E, Zalewski N, Kryzer TJ, Hinson SR, Guo Y, Dubey D, Benarroch EE, Lucchinetti CF, Pittock SJ, Lennon VA, McKeon A. Paraneoplastic neuronal intermediate filament autoimmunity. Neurology. 2018 Oct 30; 91 (18):e1677-e1689 Epub 2018 Oct 03
    View PubMed
  67. Shosha E, Dubey D, Palace J, Nakashima I, Jacob A, Fujihara K, Takahashi T, Whittam D, Leite MI, Misu T, Yoshiki T, Messina S, Elsone L, Majed M, Flanagan E, Gadoth A, Huebert C, Sagen J, Greenberg BM, Levy M, Banerjee A, Weinshenker B, Pittock SJ. Area postrema syndrome: Frequency, criteria, and severity in AQP4-IgG-positive NMOSD. Neurology. 2018 Oct 23; 91 (17):e1642-e1651 Epub 2018 Sept 26
    View PubMed
  68. Dubey D, Kothapalli N, McKeon A, Flanagan EP, Lennon VA, Klein CJ, Britton JW, So E, Boeve BF, Tillema JM, Sadjadi R, Pittock SJ. Predictors of neural-specific autoantibodies and immunotherapy response in patients with cognitive dysfunction. J Neuroimmunol. 2018 Oct 15; 323:62-72 Epub 2018 July 25
    View PubMed
  69. Dubey D, Hussain RZ, Miller-Little WA, Salter A, Doelger R, Stuve O. PDCB does not promote CNS autoimmunity in the context of genetic susceptibility but worsens its outcome. J Neuroimmunol. 2018 Oct 15; 323:53-55 Epub 2018 July 25
    View PubMed
  70. Mittal SO, Machado D, Richardson D, Dubey D, Jabbari B. Botulinum Toxin in Restless Legs Syndrome-A Randomized Double-Blind Placebo-Controlled Crossover Study. Toxins (Basel). 2018 Sep 29; 10 (10) Epub 2018 Sept 29
    View PubMed
  71. Lopez-Chiriboga AS, Klein C, Zekeridou A, McKeon A, Dubey D, Flanagan EP, Lennon VA, Tillema JM, Wirrell EC, Patterson MC, Gadoth A, Aaen JG, Brenton JN, Bui JD, Moen A, Otten C, Piquet A, Pittock SJ. LGI1 and CASPR2 neurological autoimmunity in children. Ann Neurol. 2018 Sep; 84 (3):473-480
    View PubMed
  72. Dubey D, Hinson SR, Jolliffe EA, Zekeridou A, Flanagan EP, Pittock SJ, Basal E, Drubach DA, Lachance DH, Lennon VA, McKeon A. Autoimmune GFAP astrocytopathy: Prospective evaluation of 90 patients in 1year. J Neuroimmunol. 2018 Aug 15; 321:157-163 Epub 2018 Apr 27
    View PubMed
  73. Gadoth A, Zekeridou A, Klein CJ, Thoreson CJ, Majed M, Dubey D, Flanagan EP, McKeon A, Jenkins SM, Lennon VA, Pittock SJ. Elevated LGI1-IgG CSF index predicts worse neurological outcome. Ann Clin Transl Neurol. 2018 May; 5 (5):646-650 Epub 2018 Apr 02
    View PubMed
  74. Dubey D, Toledano M, McKeon A. Clinical presentation of autoimmune and viral encephalitides. Curr Opin Crit Care. 2018 Apr; 24 (2):80-90
    View PubMed
  75. Dubey D, Lennon VA, Gadoth A, Pittock SJ, Flanagan EP, Schmeling JE, McKeon A, Klein CJ. Autoimmune CRMP5 neuropathy phenotype and outcome defined from 105 cases. Neurology. 2018 Jan 9; 90 (2):e103-e110 Epub 2017 Dec 08
    View PubMed
  76. Devine MF, Herrin C, Warnack W, Dubey D. Novel use of levodopa in human immunodeficiency virus encephalopathy-mediated parkinsonism in an adult. J Postgrad Med. 2018 Jan-Mar; 64 (1):53-55
    View PubMed
  77. Dubey D, Pittock SJ, Kelly CR, McKeon A, Lopez-Chiriboga AS, Lennon VA, Gadoth A, Smith CY, Bryant SC, Klein CJ, Aksamit AJ, Toledano M, Boeve BF, Tillema JM, Flanagan EP. Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis. Ann Neurol. 2018 Jan; 83 (1):166-177
    View PubMed
  78. Dubey D, Forsthuber T, Flanagan EP, Pittock SJ, Stuve O. B-cell-targeted therapies in relapsing forms of MS. Neurol Neuroimmunol Neuroinflamm. 2017 Nov; 4 (6):e405 Epub 2017 Oct 23
    View PubMed
  79. Mittal SO, Machado D, Richardson D, Dubey D, Jabbari B. Botulinum Toxin in Parkinson Disease Tremor: A Randomized, Double-Blind, Placebo-Controlled Study With a Customized Injection Approach. Mayo Clin Proc. 2017 Sep; 92 (9):1359-1367 Epub 2017 Aug 05
    View PubMed
  80. Tobin WO, Guo Y, Krecke KN, Parisi JE, Lucchinetti CF, Pittock SJ, Mandrekar J, Dubey D, Debruyne J, Keegan BM. Diagnostic criteria for chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS). Brain. 2017 Sep 1; 140 (9):2415-2425
    View PubMed
  81. Dubey D, Alqallaf A, Warnack W, Gupta P, Harvey J, Vernino S. Faciobrachial dystonic spells: Presenting feature of autoimmune encephalopathy. Neurol India 2017 Sep-Oct; 65 (5):1149-1151
    View PubMed
  82. Dubey D, Singh J, Britton JW, Pittock SJ, Flanagan EP, Lennon VA, Tillema JM, Wirrell E, Shin C, So E, Cascino GD, Wingerchuk DM, Hoerth MT, Shih JJ, Nickels KC, McKeon A. Predictive models in the diagnosis and treatment of autoimmune epilepsy. Epilepsia. 2017 Jul; 58 (7):1181-1189 Epub 2017 May 26
    View PubMed
  83. Gadoth A, Pittock SJ, Dubey D, McKeon A, Britton JW, Schmeling JE, Smith A, Kotsenas AL, Watson RE, Lachance DH, Flanagan EP, Lennon VA, Klein CJ. Expanded phenotypes and outcomes among 256 LGI1/CASPR2-IgG-positive patients. Ann Neurol. 2017 Jul; 82 (1):79-92
    View PubMed
  84. Wadhwa V, Jacks BB, Dubey D, Meek ME, Bricco D. Smartphone Apps as a Source of Information About Interventional Radiology. Cardiovasc Intervent Radiol 2017 Jun; 40 (6):957-958 Epub 2017 Feb 14
    View PubMed
  85. Dubey D, Alqallaf A, Hays R, Freeman M, Chen K, Ding K, Agostini M, Vernino S. Neurological Autoantibody Prevalence in Epilepsy of Unknown Etiology. JAMA Neurol. 2017 Apr 1; 74 (4):397-402
    View PubMed
  86. Dubey D, Pittock SJ, Krecke KN, Flanagan EP. Association of Extension of Cervical Cord Lesion and Area Postrema Syndrome With Neuromyelitis Optica Spectrum Disorder. JAMA Neurol. 2017 Mar 1; 74 (3):359-361
    View PubMed
  87. Dubey D, Freeman M, Neeley OJ, Carter G. Encephalopathy following melphalan administration. J Chemother. 2017 Feb; 29 (1):45-48 Epub 2016 Apr 22
    View PubMed
  88. Dubey D, Khemani P, Remster E, Elliott JL. Gradually Progressive Spastic Ataxia in a Young Man: Steadily Unsteady. JAMA Neurol. 2017 Feb 1; 74 (2):238-241
    View PubMed
  89. Menge T, Dubey D, Warnke C, Hartung HP, Stuve O. Ocrelizumab for the treatment of relapsing-remitting multiple sclerosis. Expert Rev Neurother. 2016 Oct; 16 (10):1131-9 Epub 2016 Sept 01
    View PubMed
  90. Dubey D, Devine M, Blackburn K, Warnack W. Relapsing-remitting chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids syndrome in association with P/Q-type voltage-gated calcium channel antibody. J Postgrad Med 2016 Oct-Dec; 62 (4):269-270
    View PubMed
  91. Dubey D, Farzal Z, Hays R, Brown LS, Vernino S. Evaluation of positive and negative predictors of seizure outcomes among patients with immune-mediated epilepsy: a meta-analysis. Ther Adv Neurol Disord. 2016 Sep; 9 (5):369-77 Epub 2016 July 04
    View PubMed
  92. Dubey D, Blackburn K, Greenberg B, Stuve O, Vernino S. Diagnostic and therapeutic strategies for management of autoimmune encephalopathies. Expert Rev Neurother. 2016 Aug; 16 (8):937-49 Epub 2016 May 30
    View PubMed
  93. Dubey D, Cano CA, Stuve O. Update on monitoring and adverse effects of approved second-generation disease-modifying therapies in relapsing forms of multiple sclerosis. Curr Opin Neurol. 2016 Jun; 29 (3):278-85
    View PubMed
  94. Dubey D, Cano CA, Stuve O. Update on monitoring and adverse effects of first generation disease modifying therapies and their recently approved versions in relapsing forms of multiple sclerosis. Curr Opin Neurol. 2016 Jun; 29 (3):272-7
    View PubMed
  95. Dubey D, Sguigna P, Stuve O. Managing Disability in Progressive Multiple Sclerosis. Curr Treat Options Neurol. 2016 Jun; 18 (6):27
    View PubMed
  96. Dubey D, Zhang Y, Graves D, DeSena AD, Frohman E, Greenberg B. Use of interleukin-2 for management of natalizumab-associated progressive multifocal leukoencephalopathy: case report and review of literature. Ther Adv Neurol Disord. 2016 May; 9 (3):211-5 Epub 2015 Dec 17
    View PubMed
  97. Dubey D, Kapotic M, Freeman M, Sawhney A, Rojas JC, Warnack W, Vernino S. Factors contributing to delay in diagnosis of Guillain-Barre syndrome and impact on clinical outcome. Muscle Nerve. 2016 Mar; 53 (3):384-7 Epub 2015 Aug 08
    View PubMed
  98. Dubey D, Sawhney A, Atluru A, Amritphale A, Dubey A, Trivedi J. Trends in authorship based on gender and nationality in published neuroscience literature. Neurol India. 2016 Jan-Feb; 64 (1):97-100
    View PubMed
  99. Dubey D, Sawhney A, Greenberg B, Lowden A, Warnack W, Khemani P, Stuve O, Vernino S. The spectrum of autoimmune encephalopathies. J Neuroimmunol. 2015 Oct 15; 287:93-7 Epub 2015 Aug 28
    View PubMed
  100. Dubey D, Thodeson D, Dowling M, Sirsi D, Arnold S, Said R. Type II Cortical Dysplasia in Dominant Frontal Lobe Presenting as Gelastic Epilepsy. Pediatr Neurol. 2015 Jul; 53 (1):97-8 Epub 2015 Mar 16
    View PubMed
  101. Dubey D, Samudra N, Gupta P, Agostini M, Ding K, Van Ness PC, Vernino S, Hays R. Retrospective case series of the clinical features, management and outcomes of patients with autoimmune epilepsy. Seizure. 2015 Jul; 29:143-7 Epub 2015 Apr 30
    View PubMed
  102. Dubey D, Kieseier BC, Hartung HP, Hemmer B, Warnke C, Menge T, Miller-Little WA, Stuve O. Dimethyl fumarate in relapsing-remitting multiple sclerosis: rationale, mechanisms of action, pharmacokinetics, efficacy and safety. Expert Rev Neurother. 2015 Apr; 15 (4):339-46
    View PubMed
  103. Dubey D, Steen E, Sawhney A, Stuve O. Spinal gout: A rare cause of paraplegia. Neurol India. 2015 Mar-Apr; 63 (2):284-5
    View PubMed
  104. Dubey D, Kieseier BC, Hartung HP, Hemmer B, Miller-Little WA, Stuve O. Clinical management of multiple sclerosis and neuromyelitis optica with therapeutic monoclonal antibodies: approved therapies and emerging candidates. Expert Rev Clin Immunol. 2015 Jan; 11 (1):93-108 Epub 2014 Dec 15
    View PubMed
  105. Dubey D, Cano CA, Stuve O. Intractable and highly active relapsing multiple sclerosis - role of alemtuzumab. Neuropsychiatr Dis Treat. 2015; 11:2405-14 Epub 2015 Sept 18
    View PubMed
  106. Dubey D, Amritphale A, Sawhney A, Dubey D, Srivastav N. Analysis of YouTube as a source of information for West Nile Virus infection. Clin Med Res. 2014 Dec; 12 (3-4):129-32 Epub 2014 Feb 26
    View PubMed
  107. Dubey D, Konikkara J, Modur PN, Agostini M, Gupta P, Shu F, Vernino S. Effectiveness of multimodality treatment for autoimmune limbic epilepsy. Epileptic Disord. 2014 Dec; 16 (4):494-9
    View PubMed
  108. Dubey D, Banerjee C, Sawhney A, Sharma A, Alberts MJ. Combination therapy of intravenous glycoprotein IIB/IIIA inhibitors and tissue plasminogen activator for acute ischemic stroke. Neurol India. 2014 Nov-Dec; 62 (6):631-4
    View PubMed
  109. Dubey D, Narayan RN, Motiwala A, Gupta P. Teaching NeuroImages: spherules in spine: vertebral coccidioidomycosis. Neurology. 2014 Oct 14; 83 (16):e158
    View PubMed
  110. Dubey D, Sawhney A, Sharma A, Dubey D. Paroxysmal paralytic attacks secondary to excessive cola consumption. Clin Med Res. 2014 Sep; 12 (1-2):61-4 Epub 2014 Feb 26
    View PubMed
  111. Dubey D, Modur PN. Teaching NeuroImages: partial brown-Sequard syndrome: a rare presentation of CMV myelitis. Neurology. 2014 Aug 5; 83 (6):e80
    View PubMed
  112. Dubey D, Sharma VD, Pass SE, Sawhney A, Stuve O. Para-dichlorobenzene toxicity - a review of potential neurotoxic manifestations. Ther Adv Neurol Disord. 2014 May; 7 (3):177-87
    View PubMed
  113. Dubey D, Amritphale A, Sawhney A, Amritphale N, Dubey P, Pandey A. Smart phone applications as a source of information on stroke. J Stroke. 2014 May; 16 (2):86-90 Epub 2014 May 30
    View PubMed
  114. Sharma A, Arbab-Zadeh A, Dubey D, Shani J, Lazar J, Frankel R. Access site bleeding after transcatheter aortic valve implantation. J Thromb Thrombolysis. 2013 May; 35 (4):463-8
    View PubMed
  115. Pandey A, Hasan S, Dubey D, Sarangi S. Smartphone apps as a source of cancer information: changing trends in health information-seeking behavior. J Cancer Educ. 2013 Mar; 28 (1):138-42
    View PubMed
  116. Dubey D, Raza FS, Sawhney A, Pandey A. Klebsiella pneumoniae Renal Abscess Syndrome: A Rare Case with Metastatic Involvement of Lungs, Eye, and Brain. Case Rep Infect Dis. 2013; 2013:685346 Epub 2013 Aug 05
    View PubMed
  117. Sharma A, Dubey D, Sawhney A, Janga K. GAD65 Positive Autoimmune Limbic Encephalitis: A Case Report and Review of Literature. J Clin Med Res. 2012 Dec; 4 (6):424-8 Epub 2012 Nov 11
    View PubMed
  118. Dubey D, Amritphale A, Sawhney A, Bhartee H, Chansoria M. Impact of Cerebral Palsy on Hand Preference with Special Reference to Premature Birth Pediatric Oncall. 2012.
  119. Dubey D, Sawhney A, Kavishwar A, Pande S, Dubey D. A study of anatomical, seasonal and diurnal variation in the occurrence International Journal of Collaborative Research on Internal Medicine & Public Health. 2011.
  120. Dubey D, Pandde S, Dubey P. Case of nasoethmoidal meningoencephalocele. International Journal of Collaborative Research on Internal Medicine & Public Health. 2011.